floxacillin has been researched along with amoxicillin-potassium clavulanate combination in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (27.78) | 18.2507 |
| 2000's | 3 (16.67) | 29.6817 |
| 2010's | 10 (55.56) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Catherall, EJ; Irwin, R; Mizen, LW | 1 |
| Dorman, EB; Mellow, CG; Morton, RP | 1 |
| Beale, AS; Bryant, JE; Gisby, J; Toseland, CD | 1 |
| Pillans, PI | 1 |
| Forster, I; Hürlimann, R; Navratil, F; Sennhauser, FH; Stricker, T | 1 |
| Dalton, HR; Despott, EJ; Hussaini, SH; O'Brien, CS | 1 |
| Daly, AK; Day, CP | 1 |
| Kaniwa, N; Saito, Y | 1 |
| Hripcsak, G; Overby, CL; Shen, Y | 1 |
| Bowler, IC; Buchanan, R; Crook, D; Stoesser, N | 1 |
| Beasley, S; Best, E; Burton, C; Glasgow, T; Price, N; Walker, C; Walls, T | 1 |
| Faulkner, L; Naisbitt, DJ; Park, BK; Tailor, A | 1 |
| Bayne, G; Bell, S; Davey, P; Marwick, C; Nathwani, D; Patton, A; Sneddon, J; Walker, H | 1 |
| Beck, DE; Doherty, MD; El-Assal, KS; Wride, NK | 1 |
| Aklillu, E; Makonnen, E; Petros, Z | 1 |
| How, EH; Mbakada, N; Yap, D | 1 |
| Fonville, JM; Heineken, AC; Hendriks, JGE; Van Der Steen, MCM; Van Erp, JHJ; Van Kempen, RWTM; Van Wensen, RJA; Wegdam-Blans, M | 1 |
3 review(s) available for floxacillin and amoxicillin-potassium clavulanate combination
| Article | Year |
|---|---|
Genetic association studies in drug-induced liver injury.
Topics: Adverse Drug Reaction Reporting Systems; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Antitubercular Agents; Arylamine N-Acetyltransferase; Chemical and Drug Induced Liver Injury; Diclofenac; Floxacillin; Genetic Association Studies; Genetic Predisposition to Disease; HLA-B Antigens; HLA-DR Antigens; HLA-DRB1 Chains; Humans; Phenotype; Polymorphism, Single Nucleotide; Risk Assessment; Risk Factors | 2009 |
Pharmacogenomics of severe cutaneous adverse reactions and drug-induced liver injury.
Topics: Alleles; Allopurinol; Amoxicillin-Potassium Clavulanate Combination; Azetidines; Benzylamines; Carbamazepine; Chemical and Drug Induced Liver Injury; Diclofenac; Dideoxynucleosides; Drug Hypersensitivity; Floxacillin; Genetic Markers; HLA Antigens; HLA-A Antigens; HLA-B Antigens; HLA-DQ alpha-Chains; Humans; Lapatinib; Pharmacogenetics; Quinazolines; Skin; Stevens-Johnson Syndrome; Ticlopidine | 2013 |
The chemical, genetic and immunological basis of idiosyncratic drug-induced liver injury.
Topics: Amoxicillin-Potassium Clavulanate Combination; Animals; Chemical and Drug Induced Liver Injury; Floxacillin; Humans; Isoniazid; Pharmaceutical Preparations | 2015 |
1 trial(s) available for floxacillin and amoxicillin-potassium clavulanate combination
| Article | Year |
|---|---|
Chest infection following head and neck surgery: a pilot study.
Topics: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Ampicillin; Clavulanic Acids; Drug Therapy, Combination; Floxacillin; Humans; Metronidazole; Middle Aged; Otorhinolaryngologic Diseases; Pilot Projects; Postoperative Complications; Premedication; Respiratory Tract Infections | 1990 |
14 other study(ies) available for floxacillin and amoxicillin-potassium clavulanate combination
| Article | Year |
|---|---|
Drug-induced cholestatic hepatitis from common antibiotics.
Topics: Adverse Drug Reaction Reporting Systems; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Chemical and Drug Induced Liver Injury; Cholestasis; Clavulanic Acids; Drug Therapy, Combination; Female; Floxacillin; Humans; Middle Aged | 1992 |
Efficacy of amoxycillin/clavulanic acid in experimental Staphylococcus aureus endocarditis in the rat.
Topics: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Animals; Clavulanic Acids; Drug Therapy, Combination; Endocarditis, Bacterial; Floxacillin; Male; Rats; Species Specificity; Staphylococcal Infections; Staphylococcus aureus; Time Factors; Vancomycin | 1991 |
Staphylococcal osteomyelitis--a comparison of co-amoxiclav with clindamycin and flucloxacillin in an experimental rat model.
Topics: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Animals; Clavulanic Acids; Clindamycin; Disease Models, Animal; Drug Therapy, Combination; Floxacillin; Male; Osteomyelitis; Rats; Staphylococcal Infections; Staphylococcus aureus; Tibia | 1994 |
Drug associated hepatic reactions in New Zealand: 21 years experience.
Topics: Adult; Adverse Drug Reaction Reporting Systems; Age Factors; Aged; Aged, 80 and over; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anesthetics, Inhalation; Anti-Bacterial Agents; Anti-Inflammatory Agents; Calcium Channel Blockers; Cardiovascular Agents; Cause of Death; Clavulanic Acids; Diclofenac; Drug Therapy, Combination; Drug-Related Side Effects and Adverse Reactions; Erythromycin; Female; Floxacillin; Halothane; Humans; Liver; Male; Middle Aged; New Zealand; Penicillins; Perhexiline; Steroids | 1996 |
Nonpuerperal mastitis in adolescents.
Topics: Administration, Oral; Adolescent; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Breast Cyst; Child; Clindamycin; Female; Floxacillin; Humans; Mastitis; Prolactin; Recurrence; Retrospective Studies; Staphylococcus aureus | 2006 |
Antibiotic therapy: a major cause of drug-induced jaundice in southwest England.
Topics: Age Factors; Aged; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; England; Female; Floxacillin; Humans; Incidence; Jaundice; Male; Middle Aged; Retrospective Studies; Rural Health | 2007 |
Estimating heritability of drug-induced liver injury from common variants and implications for future study designs.
Topics: Amoxicillin-Potassium Clavulanate Combination; beta-Lactamase Inhibitors; Case-Control Studies; Chemical and Drug Induced Liver Injury; Chromosomes, Human, Pair 6; Floxacillin; Genetic Predisposition to Disease; Genome-Wide Association Study; Humans | 2014 |
Multidrug-resistant Escherichia coli soft tissue infection investigated with bacterial whole genome sequencing.
Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; beta-Lactams; Ciprofloxacin; Diagnosis, Differential; Drug Resistance, Multiple, Bacterial; Ertapenem; Escherichia coli; Escherichia coli Infections; Floxacillin; Follow-Up Studies; Genome, Bacterial; Gentamicins; Humans; Liver Diseases; Male; Meropenem; Middle Aged; Sequence Analysis, DNA; Soft Tissue Infections; Thienamycins; Treatment Outcome; Vancomycin | 2014 |
Paediatric empyema in New Zealand: a tale of two cities.
Topics: Adolescent; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Cefotaxime; Cefuroxime; Child; Child, Preschool; Cohort Studies; Community-Acquired Infections; Empyema, Pleural; Ethnicity; Female; Floxacillin; Hospitals, Pediatric; Hospitals, Urban; Humans; Infant; Infant, Newborn; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; New Zealand; Pneumococcal Infections; Practice Guidelines as Topic; Retrospective Studies; Seasons; Staphylococcal Infections; Staphylococcus aureus; Streptococcal Infections; Streptococcus pneumoniae; Streptococcus pyogenes | 2015 |
Reduction in post-operative acute kidney injury following a change in antibiotic prophylaxis policy for orthopaedic surgery: an observational study.
Topics: Acute Kidney Injury; Aged; Aged, 80 and over; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Antibiotic Prophylaxis; Female; Floxacillin; Gentamicins; Health Policy; Health Services Research; Humans; Incidence; Interrupted Time Series Analysis; Male; Middle Aged; Organizational Policy; Orthopedic Procedures | 2016 |
Orbital Cellulitis Following Uncomplicated Aqueous Shunt Surgery.
Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Drug Therapy, Combination; Floxacillin; Glaucoma Drainage Implants; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Levofloxacin; Male; Middle Aged; Orbital Cellulitis; Postoperative Complications; Retrospective Studies; Tomography, X-Ray Computed | 2017 |
Genome-Wide Association Studies for Idiosyncratic Drug-Induced Hepatotoxicity: Looking Back-Looking Forward to Next-Generation Innovation.
Topics: Amoxicillin-Potassium Clavulanate Combination; Cell Adhesion Molecules; Chemical and Drug Induced Liver Injury; Diclofenac; Floxacillin; Genome-Wide Association Study; Genotype; HLA-B Antigens; HLA-DQ beta-Chains; HLA-DRB1 Chains; Humans; Lapatinib; Liver; Proteins; Quinazolines | 2017 |
An exotic abscess within the United Kingdom from The Gambia: a case report.
Topics: Abscess; Adult; Amoxicillin-Potassium Clavulanate Combination; Animals; Anti-Bacterial Agents; Emergency Service, Hospital; Female; Floxacillin; Gambia; Humans; Larva; Myiasis; Thigh; Travel-Related Illness; Treatment Outcome; United Kingdom | 2017 |
Optimization of the empirical antibiotic choice during the treatment of acute prosthetic joint infections: a retrospective analysis of 91 patients.
Topics: Acute Disease; Aged; Aged, 80 and over; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cefazolin; Clinical Decision-Making; Combined Modality Therapy; Debridement; Female; Floxacillin; Hip Prosthesis; Humans; Knee Prosthesis; Male; Microbial Sensitivity Tests; Middle Aged; Netherlands; Practice Patterns, Physicians'; Prosthesis-Related Infections; Retrospective Studies; Staphylococcal Infections | 2019 |